Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) [Parenthetical]

v2.4.0.6
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) [Parenthetical] (USD $)
 7 Months Ended 12 Months Ended
Dec. 31, 2007
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Price per share issued to founders for intellectual property $ 0.15     $ 0.226  
Price per share issued for services $ 0.15   $ 0.36    
Price per share conversion of senior convertible notes into capital stock         $ 0.13
Price per share issued to directors, employees and consultants     $ 0.23 $ 0.238 $ 0.15
Price per share conversion of demand notes into capital stock       $ 0.23  
Price per share conversion of accrued interest on demand notes into capital stock       $ 0.23  
Price per share of capital stock       $ 0.23  
Price per share of capital preferred stock     $ 0.23    
Price per share issued to holders of convertible debentures one   $ 0.62      
Price per share issued of common stock   $ 0.62      
Stock issuance costs (in dollars)   $ 435,713      
Price per share issued to holders of convertible debentures Two   $ 0.30      
Price per share issued of common stock   $ 0.40      
Common and warrants issue expenses (in dollars)   $ 70,000